Adjuvant PEG Intron in Ulcerated Melanoma

Clinical trial NCT01502696 · UNKNOWN

Trial details

NCT number: NCT01502696
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Ulcerated Melanomas

Start date: 2012-10-01
Primary completion: 2019-04-01
Enrollment: 1200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.